SEARCH

SEARCH BY CITATION

References

  • Bullinger, L., Dohner, K., Bair, E., Frohling, S., Schlenk, R.F., Tibshirani, R., Dohner, H. & Pollack, J.R. (2004) Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. The New England Journal of Medicine, 350, 16051616.
  • Cao, W., Britos-Bray, M., Claxton, D.F., Kelley, C.A., Speck, N.A., Liu, P.P. & Friedman, A.D. (1997) CBFβ-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells. Oncogene, 15, 13151327.
  • Castilla, L.H., Wijmenga, C., Wang, Q., Stacy, T., Speck, N.A., Eckhaus, M., Marin-Padilla, M., Collins, F.S., Wynshaw-Boris, A. & Liu, P.P. (1996) Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFβ-MYH11. Cell, 87, 687696.
  • Debernardi, S., Lillington, D.M., Chaplin, T., Tomlinson, S., Amess, J., Rohatiner, A., Lister, T.A. & Young, B.D. (2003) Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events. Genes, Chromosomes & Cancer, 37, 149158.
  • Erickson, P., Gao, J., Chang, K.S., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J. & Drabkin, H. (1992) Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood, 80, 18251831.
  • Gutierrez, N.C., Lopez-Perez, R., Hernandez, J.M., Isidro, I., Gonzalez, B., Delgado, M., Ferminan, E., Garcia, J.L., Vazquez, L., Gonzalez, M. & San Miguel, J.F. (2005) Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia. Leukemia, 19, 402409.
  • Hurwitz, C.A., Raimondi, S.C., Head, D., Krance, R., Mirro, Jr J., Kalwinsky, D.K., Ayers, G.D. & Behm, F.G. (1992) Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood, 80, 31823188.
  • Kitabayashi, I., Ida, K., Morohoshi, F., Yokoyama, A., Mitsuhashi, N., Shimizu, K., Nomura, N., Hayashi, Y. & Ohki, M. (1998) The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1. Molecular and Cellular Biology, 18, 846858.
  • Kohlmann, A., Schoch, C., Schnittger, S., Dugas, M., Hiddemann, W., Kern, W. & Haferlach, T. (2003) Molecular characterization of acute leukemias by use of microarray technology. Genes, Chromosomes & Cancer, 37, 396405.
  • Lawrence, H.J., Rozenfeld, S., Cruz, C., Matsukuma, K., Kwong, A., Komuves, L., Buchberg, A.M. & Largman, C. (1999) Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Leukemia, 13, 19931999.
  • Liu, P., Tarle, S.A., Hajra, A., Claxton, D.F., Marlton, P., Freedman, M., Siciliano, M.J. & Collins, F.S. (1993) Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science, 261, 10411044.
  • Look, A.T. (1997) Oncogenic transcription factors in the human acute leukemias. Science, 278, 10591064.
  • Lou, J., Cao, W., Bernardin, F., Ayyanathan, K., Rauscher, III F.J. & Friedman, A.D. (2000) Exogenous cdk4 overcomes reduced cdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF – a model for overcoming inhibition of proliferation by CBF oncoproteins. Oncogene, 19, 26952703.
  • Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y. & Ohki, M. (1991) t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proceedings of the National Academy of Sciences of the United States of America, 88, 1043110434.
  • Miyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N. & Ohki, M. (1993) The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. The EMBO Journal, 12, 27152721.
  • Nakamura, T., Largaespada, D.A., Lee, M.P., Johnson, L.A., Ohyashiki, K., Toyama, K., Chen, S.J., Willman, C.L., Chen, I.M., Feinberg, A.P., Jenkins, N.A., Copeland, N.G. & Shaughnessy, Jr, J.D. (1996) Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nature Genetics, 12, 154158.
  • Osato, M., Asou, N., Okubo, T., Nishimura, S., Yamasaki, H., Era, T., Suzushima, H., Kawano, F., Matsuoka, R., Oka, H., Bae, S.C., Ito, Y. & Takatsuki, K. (1997) Myelomonoblastic leukaemia cells carrying the PEBP2β/MYH11 fusion gene are CD34+, c-KIT+ immature cells. British Journal of Haematology, 97, 656658.
  • Peterson, L.F. & Zhang, D.E. (2004) The 8;21 translocation in leukemogenesis. Oncogene, 23, 42554262.
  • Ross, M.E., Mahfouz, R., Onciu, M., Liu, H.C., Zhou, X., Song, G., Shurtleff, S.A., Pounds, S., Cheng, C., Ma, J., Ribeiro, R.C., Rubnitz, J.E., Girtman, K., Williams, W.K., Raimondi, S.C., Liang, D.C., Shih, L.Y., Pui, C.H. & Downing, J.R. (2004) Gene expression profiling of pediatric acute myelogenous leukemia. Blood, 104, 36793687.
  • Schoch, C., Kohlmann, A., Schnittger, S., Brors, B., Dugas, M., Mergenthaler, S., Kern, W., Hiddemann, W., Eils, R. & Haferlach, T. (2002) Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proceedings of the National Academy of Sciences of the United States of America, 99, 1000810013.
  • Shigesada, K., Van De Sluis, B. & Liu, P.P. (2004) Mechanism of leukemogenesis by the inv(16) chimeric gene CBFβ/PEBP2β-MHY11. Oncogene, 23, 42974307.
  • Speck, N.A. & Gilliland, D.G. (2002) Core-binding factors in haematopoiesis and leukaemia. Nature Reviews Cancer, 2, 502513.
  • Valk, P.J.M., Verhaak, R.G.W., Beijen, M.A., Erpelinck, C.A.J., Van Doorn-Khosrovani, S.Bv.W., Boer, J.M., Beverloo, H.B., Moorhouse, M.J., Van Der Spek, P.J., Lowenberg, B. & Delwel, R. (2004) Prognostically useful gene-expression profiles in acute myeloid leukemia. The New England Journal of Medicine, 350, 16171628.
  • Yagi, T., Morimoto, A., Eguchi, M., Hibi, S., Sako, M., Ishii, E., Mizutani, S., Imashuku, S., Ohki, M. & Ichikawa, H. (2003) Identification of a gene expression signature associated with pediatric AML prognosis. Blood, 102, 18491856.
  • Yergeau, D.A., Hetherington, C.J., Wang, Q., Zhang, P., Sharpe, A.H., Binder, M., Marin-Padilla, M., Tenen, D.G., Speck, N.A. & Zhang, D.E. (1997) Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nature Genetics, 15, 303306.
  • Zhang, J., Kalkum, M., Yamamura, S., Chait, B.T. & Roeder, R.G. (2004) E protein silencing by the leukemogenic AML1-ETO fusion protein. Science, 305, 12861289.